Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Envoy Medical (COCHW) Return on Sales (2022 - 2025)

Historic Return on Sales for Envoy Medical (COCHW) over the last 4 years, with Q3 2025 value amounting to 147.12%.

  • Envoy Medical's Return on Sales fell 536200.0% to 147.12% in Q3 2025 from the same period last year, while for Sep 2025 it was 107.73%, marking a year-over-year decrease of 290900.0%. This contributed to the annual value of 89.21% for FY2024, which is 311100.0% down from last year.
  • According to the latest figures from Q3 2025, Envoy Medical's Return on Sales is 147.12%, which was down 536200.0% from 73.0% recorded in Q2 2025.
  • In the past 5 years, Envoy Medical's Return on Sales ranged from a high of 99.83% in Q3 2022 and a low of 147.12% during Q3 2025
  • For the 4-year period, Envoy Medical's Return on Sales averaged around 64.01%, with its median value being 73.29% (2024).
  • Within the past 5 years, the most significant YoY rise in Envoy Medical's Return on Sales was 296700bps (2023), while the steepest drop was -1421400bps (2023).
  • Over the past 4 years, Envoy Medical's Return on Sales (Quarter) stood at 100.44% in 2022, then increased by 30bps to 70.77% in 2023, then plummeted by -66bps to 117.45% in 2024, then dropped by -25bps to 147.12% in 2025.
  • Its last three reported values are 147.12% in Q3 2025, 73.0% for Q2 2025, and 121.78% during Q1 2025.